이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Star Lake BioscienceZhaoqing Guangdong 미래 성장

Future 기준 확인 1/6

Star Lake BioscienceZhaoqing Guangdong (는) 각각 연간 16.6% 및 4.7% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 21.6% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 13.6% 로 예상됩니다.

주요 정보

18.5%

수익 성장률

18.5%

EPS 성장률

Food 수익 성장	30.3%
매출 성장률	3.3%
향후 자기자본 수익률	14.7%
애널리스트 커버리지	Low
마지막 업데이트	29 Jul 2024

최근 미래 성장 업데이트

업데이트 없음

Recent updates

Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Ticks All The Boxes When It Comes To Earnings Growth

Jul 26

Estimating The Intrinsic Value Of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHSE:600866)

May 28

There's No Escaping Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Muted Earnings Despite A 26% Share Price Rise

Apr 29

수익 및 매출 성장 예측

SHSE:600866 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (CNY Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	18,975	1,407	N/A	3,181	2
12/31/2025	18,344	1,256	N/A	1,515	2
12/31/2024	17,600	1,077	N/A	2,376	2
3/31/2024	17,410	809	2,150	2,512	N/A
12/31/2023	17,374	678	1,650	2,026	N/A
9/30/2023	17,343	598	1,231	1,503	N/A
6/30/2023	16,932	429	1,345	1,680	N/A
3/31/2023	17,479	546	445	845	N/A
12/31/2022	17,486	608	1,210	1,663	N/A
9/30/2022	16,084	595	1,493	2,009	N/A
6/30/2022	12,294	497	181	630	N/A
3/31/2022	7,938	301	-78	312	N/A
12/31/2021	4,071	152	-182	168	N/A
9/30/2021	1,170	96	-38	171	N/A
6/30/2021	1,129	130	-123	142	N/A
3/31/2021	1,134	151	-114	210	N/A
12/31/2020	1,116	149	-40	250	N/A
9/30/2020	1,011	137	-150	159	N/A
6/30/2020	1,081	156	-104	171	N/A
3/31/2020	1,038	145	2	183	N/A
12/31/2019	1,050	150	56	213	N/A
9/30/2019	1,061	132	136	226	N/A
6/30/2019	969	103	150	181	N/A
3/31/2019	926	71	75	104	N/A
12/31/2018	859	42	17	51	N/A
9/30/2018	849	-82	-23	16	N/A
6/30/2018	852	-101	-21	28	N/A
3/31/2018	805	-124	25	72	N/A
12/31/2017	687	-158	N/A	50	N/A
9/30/2017	668	-35	N/A	52	N/A
6/30/2017	634	1	N/A	34	N/A
3/31/2017	638	22	N/A	28	N/A
12/31/2016	680	24	N/A	41	N/A
9/30/2016	618	-232	N/A	11	N/A
6/30/2016	621	-333	N/A	2	N/A
3/31/2016	656	-397	N/A	-11	N/A
12/31/2015	730	-422	N/A	3	N/A
9/30/2015	882	-312	N/A	60	N/A
6/30/2015	923	-319	N/A	89	N/A
3/31/2015	912	-353	N/A	53	N/A
12/31/2014	871	-361	N/A	-20	N/A
9/30/2014	819	-163	N/A	-57	N/A
6/30/2014	817	-77	N/A	-58	N/A
3/31/2014	856	19	N/A	-81	N/A
12/31/2013	903	20	N/A	-28	N/A
9/30/2013	1,050	-145	N/A	-96	N/A

애널리스트 미래 성장 예측

수입 대 저축률: 600866 의 연간 예상 수익 증가율( 16.6% )이 saving rate( 2.9% 보다 높습니다. ).

수익 vs 시장: 600866 의 연간 수익( 16.6% ) CN 시장( 22.6% 보다 느리게 성장할 것으로 예상됩니다. 22.6% 연간).

고성장 수익: 600866 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: 600866 의 수익(연간 4.7% ) CN 시장( 13.9% 보다 느리게 성장할 것으로 예상됩니다. 13.9% 연간).

고성장 수익: 600866 의 수익(연간 4.7% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 600866 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 13.6 %).

Star Lake BioscienceZhaoqing Guangdong 미래 성장

Future 기준 확인 1/6

주요 정보

최근 미래 성장 업데이트

Recent updates

Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Ticks All The Boxes When It Comes To Earnings Growth

Now 20% undervalued

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report First Half, 2024 Results on Aug 27, 2024

Estimating The Intrinsic Value Of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHSE:600866)

New minor risk - Share price stability

Now 23% overvalued after recent price rise

Investor sentiment improves as stock rises 28%

There's No Escaping Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Muted Earnings Despite A 26% Share Price Rise

New minor risk - Financial position

First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.073 in 1Q 2023)

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong, Annual General Meeting, May 13, 2024

Investor sentiment improves as stock rises 25%

Now 21% undervalued after recent price drop

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report Q1, 2024 Results on Apr 23, 2024

Now 21% undervalued after recent price drop

Now 23% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 19%

Now 23% undervalued after recent price drop

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report Fiscal Year 2023 Results on Apr 23, 2024

Third quarter 2023 earnings released: EPS: CN¥0.16 (vs CN¥0.053 in 3Q 2022)

New minor risk - Profit margin trend

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report First Half, 2023 Results on Aug 29, 2023

Full year 2022 earnings released: EPS: CN¥0.51 (vs CN¥0.14 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.053 (vs CN¥0.005 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.075 (vs CN¥0.056 in 2Q 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.005 (vs CN¥0.035 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.056 (vs CN¥0.07 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.047 (vs CN¥0.044 in 1Q 2020)

New 90-day low: CN¥3.77

New 90-day low: CN¥4.39

New 90-day high: CN¥4.95

New 90-day low: CN¥4.42

Third quarter earnings released

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report Q3, 2020 Results on Oct 27, 2020

New 90-day high - CN¥5.57

First half earnings released

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report First Half, 2020 Results on Aug 25, 2020

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견